ID   IARC-309
AC   CVCL_IV27
SY   IARC 309; IARC/309; IARC309
DR   Wikidata; Q54897138
RX   PubMed=1620543;
RX   PubMed=3004968;
RX   PubMed=3934070;
RX   PubMed=8108117;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C156 ! BL-67
OI   CVCL_A1DZ ! BL-78
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 9
//
RX   PubMed=1620543;
RA   Apel T.W., Mautner J., Polack A., Bornkamm G.-W., Eick D.;
RT   "Two antisense promoters in the immunoglobulin mu-switch region drive
RT   expression of c-myc in the Burkitt's lymphoma cell line BL67.";
RL   Oncogene 7:1267-1271(1992).
//
RX   PubMed=3004968; DOI=10.1002/j.1460-2075.1985.tb04140.x; PMCID=PMC554723;
RA   Eick D., Piechaczyk M., Henglein B., Blanchard J.-M., Traub B.,
RA   Kofler E., Wiest S., Lenoir G.M., Bornkamm G.-W.;
RT   "Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer
RT   half-lives.";
RL   EMBO J. 4:3717-3725(1985).
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=8108117;
RA   Albert T., Urlbauer B., Kohlhuber F., Hammersen B., Eick D.;
RT   "Ongoing mutations in the N-terminal domain of c-Myc affect
RT   transactivation in Burkitt's lymphoma cell lines.";
RL   Oncogene 9:759-763(1994).
//